Skip to content

Opening book details…

About this Medicine article

High clinical and morphologic response using90Y-DOTA-octreotate sequenced with177Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours by Kong, Grace; Callahan, Jason; Hofman, Michael S.; Pattison, David A.; Akhurst, Tim; Michael, Michael; Eu, Peter; Hicks, Rodney J. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Kong, Grace; Callahan, Jason; Hofman, Michael S.; Pattison, David A.; Akhurst, Tim; Michael, Michael; Eu, Peter; Hicks, Rodney J.
Publisher
Springer; Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 0340-6997)
Published
2016
Language
EN
Field
Medicine (Health Sciences)

More by Kong, Grace; Callahan, Jason; Hofman, Michael S.; Pattison, David A.; Akhurst, Tim; Michael, Michael; Eu, Peter; Hicks, Rodney J.

Browse all works by Kong, Grace; Callahan, Jason; Hofman, Michael S.; Pattison, David A.; Akhurst, Tim; Michael, Michael; Eu, Peter; Hicks, Rodney J.